Advertisement

Current Challenges in the Diagnosis of Fungal Infections

  • Cornelia Lass-FlörlEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1508)

Abstract

Diagnosing fungal infections is a challenge, particularly in the immunocompromised host. Signs and symptoms are nonspecific, colonization is difficult to distinguish from invasive disease, blood cultures are commonly negative, and patients are often unable to undergo invasive diagnostic procedures. Culture and microscopic examination remain the “gold standard” but are insensitive. Antigen assays such as the galactomannan and glucan detection systems are frequently used, yet these tests vary in sensitivity and specificity, depending on the patient population involved. Molecular-based assays are not yet clinically validated.

Key words

Fungal infections Galactomannan assay Glucan assay PCR Microscopic examination Culture 

References

  1. 1.
    Schelenz S, Barnes RA, Barton RC et al (2015) British Society for medical mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis 15:461–474CrossRefPubMedGoogle Scholar
  2. 2.
    Lackner M, Lass-Flörl C (2013) Up-date on diagnostic strategies of invasive aspergillosis. Curr Pharm Design 19:3595–3614CrossRefGoogle Scholar
  3. 3.
    Lackner M, Caramalho R, Lass-Flörl C (2014) Laboratory diagnosis of mucormycosis: current status and future perspectives. Future Microbiol 9:683–695CrossRefPubMedGoogle Scholar
  4. 4.
    Cornely OA, Arikan-Akdagli S, Dannaoui E et al (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20:5–26CrossRefPubMedGoogle Scholar
  5. 5.
    Walsh TJ, Anaissie EJ, Denning DW (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360CrossRefPubMedGoogle Scholar
  6. 6.
    Tortorano AM, Richardson M, Roilides E (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20:27–46Google Scholar
  7. 7.
    Arendrup MC, Boekhout T, Akova M (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 20:76–98CrossRefPubMedGoogle Scholar
  8. 8.
    Cuenca-Estrella M, Verweij PE, Arendrup MC (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18:9–18Google Scholar
  9. 9.
    Chowdhary A, Meis JF, Guarro J (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 20:47–75CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Division of Hygiene and Medical MicrobiologyMedical University of InnsbruckInnsbruckAustria

Personalised recommendations